Literature DB >> 22314848

Feasibility study of exploring a T₁-weighted dynamic contrast-enhanced MR approach for brain perfusion imaging.

Yudong Zhang1, Jing Wang, Xiaoying Wang, Jue Zhang, Jing Fang, Xuexiang Jiang.   

Abstract

PURPOSE: To investigate the feasibility of T(1) -weighted dynamic contrast-enhanced (DCE) MRI for the measurement of brain perfusion.
MATERIALS AND METHODS: Dynamic imaging was performed on a 3.0 Tesla (T) MR scanner by using a rapid spoiled-GRE protocol. T(1) measurement with driven equilibrium single pulse observation of T(1) (DESPOT1) was used to convert the MR signal to tracer concentration. Cerebral perfusion maps were obtained by using an improved gamma-variate model in 10 subjects and compared with those with arterial spin label (ASL) approach.
RESULTS: The cerebral blood volume (CBV) values were calculated as 4.74 ± 1.09 and 2.29 ± 0.58 mL/100 g in gray matter (GM) and whiter matter (WM), respectively. Mean transit time (MTT) values were 6.15 ± 0.59 s in GM and 6.96 ± 0.79 s in WM. The DCE values for GM/WM cerebral blood flow (CBF) were measured as 53.41 ± 9.23 / 25.78 ± 8.91 mL/100 g/min, versus ASL values of 49.05 ± 10.81 / 23.00 ± 5.89 mL/100 g/min for GW/WM. Bland-Altman plot revealed a small difference of CBF between two approaches (mean bias = 3.83 mL/100 g/min, SD = 11.29). There were 6 pairs of samples (5%, 6/120) beyond the 95% limits of agreement. The correlation plots showed that the slop of Y (CBF_(_DCE)) versus X intercept (CBF_(_ASL)) is 0.95 with the intercept of 4.53 mL/100 g/min (r = 0.74; P < 0.05).
CONCLUSION: It is feasible to evaluate the cerebral perfusion by using T(1)-weighted DCE-MRI with the improved kinetic model.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22314848     DOI: 10.1002/jmri.23570

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  2 in total

1.  Glioma: Application of histogram analysis of pharmacokinetic parameters from T1-weighted dynamic contrast-enhanced MR imaging to tumor grading.

Authors:  S C Jung; J A Yeom; J-H Kim; I Ryoo; S C Kim; H Shin; A L Lee; T J Yun; C-K Park; C-H Sohn; S-H Park; S H Choi
Journal:  AJNR Am J Neuroradiol       Date:  2014-01-02       Impact factor: 3.825

2.  MR-based hypoxia measures in human glioma.

Authors:  Vivien Tóth; Annette Förschler; Nuria M Hirsch; Jürgen den Hollander; Hendrik Kooijman; Jens Gempt; Florian Ringel; Jürgen Schlegel; Claus Zimmer; Christine Preibisch
Journal:  J Neurooncol       Date:  2013-08-07       Impact factor: 4.130

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.